Trial Profile

A Phase 1 trial with ART-101

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 28 Jun 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs ART-101-Archeus-Technologies (Primary)
Indications Prostate cancer
Focus Diagnostic use; First in man

Most Recent Events

20 Jun 2025 According to Archeus Technologies media release, the USFDA has cleared the IND application for ART 101 enabling the company to initiate a Phase 1 clinical trial in men with metastatic castration-resistant prostate cancer (mCRPC), which is expected to start later this year.
16 Jun 2025 New trial record
29 May 2025 According to Archeus Technologies media release, trial initiation planned for 2025.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com